The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas.
Dash S, Hanson S, King B, Nyswaner K, Foss K, Tesi N, Harvey MJB, Navarro-Marchal SA, Woods A, Poradosu E, Unciti-Broceta A, Carragher NO, Brognard J.
Dash S, et al. Among authors: harvey mjb.
J Biol Chem. 2024 Sep;300(9):107615. doi: 10.1016/j.jbc.2024.107615. Epub 2024 Jul 31.
J Biol Chem. 2024.
PMID: 39089584
Free PMC article.